Company: MYGN
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0000899923-25-000112
Chunk: 52

Company: MYRIAD GENETICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 52
---
,(in millions)20252024ChangeCash flows used in operating activities$(8.8)$(15.3)$6.5 Cash flows used in investing activities(21.4)(6.0)(15.4)Cash flows provided by (used in) financing activities72.4 (9.5)81.9 Effect of foreign exchange rates on cash, cash equivalents, and restricted cash0.7 (0.3)1.0 Net increase (decrease) in cash, cash equivalents, and restricted cash42.9 (31.1)74.0 Cash, cash equivalents, and restricted cash at the beginning of the period111.9 140.9 (29.0)Cash, cash equivalents, and restricted cash at the end of the period$154.8 $109.8 $45.0 

Cash Flows from Operating Activities

We used $6.5 million less cash for operating activities for the nine months ended September 30, 2025 compared to the same period in the prior year. The decrease in cash used for operating activities was primarily driven by changes in working capital.

Cash Flows from Investing Activities

We used $15.4 million more cash for investing activities for the nine months ended September 30, 2025 compared to the same period in the prior year.  In fiscal year 2024, we had cash inflows from the maturities of investments and the sale of our EndoPredict business, which did not occur in 2025.

Cash Flows from Financing Activities

Cash flows from financing activities increased $81.9 million for the nine months ended September 30, 2025 compared to the same period in the prior year, primarily due to an increase of cash proceeds from our new Credit Facility of  $76.1 million, net of the repayment of our prior ABL Facility and debt issuance costs related to the term loan.   

Effects of Inflation

While inflation returned to more moderate levels in 2024 and 2025, inflation has had, and may continue to have, an impact on the labor costs we incur to attract and retain qualified personnel, costs to generate sales and produce testing results, and costs of laboratory supplies. If inflation were to increase, it may negatively impact our profitability and may adversely affect our business, financial condition and results of operations. In addition, increased inflation has had, and may continue to have, an effect on interest rates. An increase in